Skip to main content
NVDA-2.25%AAPL+1.57%GOOGL-0.06%MSFT+0.03%AMZN+0.06%TSM-1.07%SPCX+2.86%AVGO-0.14%META-0.24%TSLA-0.42%SKHY-3.56%MU-4.74%BRK-B-0.27%LLY+0.22%JPM-0.67%AMD-3.20%WMT+0.17%V-0.02%XOM+0.42%ASMLa-1.66%JNJ-0.47%INTC-4.99%MA-0.34%0700.HK-1.94%ORCL-2.93%1398.HK+0.79%BAC-0.62%ABBV+0.39%CSCO-0.88%CVX-0.17%COST+0.13%LRCX-4.58%KO+1.03%CAT-1.61%AMAT-2.27%0005.HK-0.78%AP2d-1.55%UNH-0.51%DELL-3.43%HSBA.L-1.30%MS-0.69%PG-0.16%GE-0.24%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.12%HD-1.18%GS-0.90%0939.HK+1.66%NZDJPY-2.59%AUDJPY-1.84%CHFJPY-1.57%NZDCAD-1.46%EURNZD+1.42%GBPNZD+1.37%USDJPY-1.32%NZDUSD-1.31%GBPJPY-1.24%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.06%USDZAR+0.91%EURZAR+0.84%AUDNZD+0.78%GBPZAR+0.76%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.67%EURAUD+0.64%GBPAUD+0.59%CHFNOK+0.55%CHFSEK+0.54%AUDUSD-0.53%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.37%EURCHF+0.35%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.26%EURPLN+0.24%SGDJPY+0.21%USDSGD+0.21%USDILS+0.16%NZDMXN-0.16%USDCAD-0.16%EURSGD+0.14%GBPCAD-0.11%PLNJPY+0.11%USDTRY+0.11%EURUSD+0.09%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%GBPUSD+0.08%EURCAD-0.07%USDDKK+0.07%GBPSGD+0.05%EURGBP+0.04%USDCOP-0.04%EURCNH+0.03%AUDNOK+0.02%USDHKD+0.01%EURDKK0.00%CHFSGD0.00%XPTUSD-5.44%UKOIL+4.82%XAGUSD-4.74%HG1-4.74%GAGUSD-4.72%USOIL+4.60%SUGAR+2.62%GAUUSD-1.00%XAUUSD-0.99%COTTON+0.71%COFFEE-0.61%XNGUSD+0.61%BTCUSD-1.69%ETHUSD-1.16%USDTUSD-0.03%XRPUSD-3.13%SOLUSD-2.14%TRXUSDT-0.03%ZECUSDT-7.21%DOGEUSD-3.27%XMRUSDT-1.52%LINKUSD-1.88%XLMUSD-2.42%BCHUSDT-10.66%LTCUSD-2.36%UNIUSD-3.05%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.11%TAOUSDT-5.96%AAVEUSD-3.34%DOTUSDT-3.52%ICPUSDT-1.44%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.46%ATOMUSDT-5.13%JUPUSDT-4.25%INJUSDT-5.65%STXUSDT-4.53%FETUSDT-4.15%TIAUSDT-2.18%PYTHUSDT-1.47%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.91%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.03%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.41%EOSUSDT-1.67%DYDXUSDT-3.58%ORDIUSDT-1.88%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.25%AAPL+1.57%GOOGL-0.06%MSFT+0.03%AMZN+0.06%TSM-1.07%SPCX+2.86%AVGO-0.14%META-0.24%TSLA-0.42%SKHY-3.56%MU-4.74%BRK-B-0.27%LLY+0.22%JPM-0.67%AMD-3.20%WMT+0.17%V-0.02%XOM+0.42%ASMLa-1.66%JNJ-0.47%INTC-4.99%MA-0.34%0700.HK-1.94%ORCL-2.93%1398.HK+0.79%BAC-0.62%ABBV+0.39%CSCO-0.88%CVX-0.17%COST+0.13%LRCX-4.58%KO+1.03%CAT-1.61%AMAT-2.27%0005.HK-0.78%AP2d-1.55%UNH-0.51%DELL-3.43%HSBA.L-1.30%MS-0.69%PG-0.16%GE-0.24%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.12%HD-1.18%GS-0.90%0939.HK+1.66%NZDJPY-2.59%AUDJPY-1.84%CHFJPY-1.57%NZDCAD-1.46%EURNZD+1.42%GBPNZD+1.37%USDJPY-1.32%NZDUSD-1.31%GBPJPY-1.24%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.06%USDZAR+0.91%EURZAR+0.84%AUDNZD+0.78%GBPZAR+0.76%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.67%EURAUD+0.64%GBPAUD+0.59%CHFNOK+0.55%CHFSEK+0.54%AUDUSD-0.53%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.37%EURCHF+0.35%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.26%EURPLN+0.24%SGDJPY+0.21%USDSGD+0.21%USDILS+0.16%NZDMXN-0.16%USDCAD-0.16%EURSGD+0.14%GBPCAD-0.11%PLNJPY+0.11%USDTRY+0.11%EURUSD+0.09%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%GBPUSD+0.08%EURCAD-0.07%USDDKK+0.07%GBPSGD+0.05%EURGBP+0.04%USDCOP-0.04%EURCNH+0.03%AUDNOK+0.02%USDHKD+0.01%EURDKK0.00%CHFSGD0.00%XPTUSD-5.44%UKOIL+4.82%XAGUSD-4.74%HG1-4.74%GAGUSD-4.72%USOIL+4.60%SUGAR+2.62%GAUUSD-1.00%XAUUSD-0.99%COTTON+0.71%COFFEE-0.61%XNGUSD+0.61%BTCUSD-1.69%ETHUSD-1.16%USDTUSD-0.03%XRPUSD-3.13%SOLUSD-2.14%TRXUSDT-0.03%ZECUSDT-7.21%DOGEUSD-3.27%XMRUSDT-1.52%LINKUSD-1.88%XLMUSD-2.42%BCHUSDT-10.66%LTCUSD-2.36%UNIUSD-3.05%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.11%TAOUSDT-5.96%AAVEUSD-3.34%DOTUSDT-3.52%ICPUSDT-1.44%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.46%ATOMUSDT-5.13%JUPUSDT-4.25%INJUSDT-5.65%STXUSDT-4.53%FETUSDT-4.15%TIAUSDT-2.18%PYTHUSDT-1.47%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.91%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.03%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.41%EOSUSDT-1.67%DYDXUSDT-3.58%ORDIUSDT-1.88%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
RT

Rapport Therapeutics, Inc. Common Stock (RAPP)

NASDAQ • Healthcare

$43.89
-$2.2 (-4.8%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$45.17
Previous Close$43.89
Day Range$43.13 - $45.42
Avg. Volume (3M)283.1K
Market Cap$2B
52 Week Range
$22.06$52.93
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$20M
Net Income (TTM)
-$137.1M
EPS (TTM)
-$3.04
ROA (TTM)
-29.88%
Current Ratio
15.72

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-10.8%Q1 2026-$0.72
+25.0%Q2 2026-$0.42
-6.2%Q3 2026-$1.19
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -6.2%

Rapport Therapeutics’ second fiscal quarter of 2026 results (based on preliminary figures reported August 5, 2026) missed expectations on EPS, with EPS of -$1.19 trailing the -$1.12 estimate by -$0.07, as the CNS-focused biotech continued to run operating losses tied to advancing its pipeline, including the RAP-219 program for indications such as epilepsy and pain. The company posted a GAAP net loss of roughly $56.6 million, down 111.8% year over year from a net loss of about $26.7 million a year ago, while operating income was about -$60.8 million. On the bottom line, EPS was down 58.7% from -$0.75 a year earlier. Cash generation remained negative, with operating cash flow of roughly -$41.5 million during the quarter. For the next period, consensus calls for EPS of -$1.21.

View full earnings history

About Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. is a small-cap biotechnology company listed on the NASDAQ as RAPP that discovers and develops small-molecule medicines for central nervous system disorders. The company works in drug development rather than commercial sales, with a pipeline centered on targeted therapies for epilepsy, pain, bipolar disorder, and hearing-related conditions.

Name
Rapport Therapeutics, Inc. Common Stock
CEO
Abraham N. Ceesay
Website
www.rapportrx.com
Industry
Healthcare
Year Founded
2022
Employees
84

Today's Snapshot

AI-generated

RAPP opened 1.2% lower at 43.35, while its sector was flat.

Trading Volume

Below 10d avg (290.3K)

40.4K

vs S&P 500 Today

Underperforming Market

-0.56%

Updated: September 10, 2026 at 14:45 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
RAPP registers a neutral stance as short-term indicators point to weakness while longer-term averages remain supportive, producing a balance of opposing signals. Momentum and CCI are notably negative and ADX signals a reasonably strong trend, yet MACD and RSI are subdued and Bollinger Bands indicate the price near the lower band, suggesting recent oversold readings. Volume trends are soft and volatility is elevated, which leaves the picture ambiguous between short-term pressure and longer-term support. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$36.25 - $46.85
    Sell
  • RSI (14)38.11
    Neutral
  • Stochastic %K (14, 3, 3)10.45
    Buy
  • MACD Level (12, 26)0.11
    Neutral

Peers & Related Assets

NRIXNurix Therapeutics, Inc.
$26.26+0.5%
URGNUroGen Pharma Ltd.
$45+2.7%
KODKodiak Sciences Inc.
$33.78-3.7%
XNCRXencor, Inc.
$24.94-1.5%
SEPNSepterna Inc
$37.97+1.6%
ANABAnaptysBio, Inc.
$55.7-1.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.